Hosted on MSN

Statins and Cholesterol Control: How do doctors assess the effectiveness of statin drugs?

Statins Relative Risk Reduction: Statin medications are prescribed to reduce the risk of heart disease and heart attack. However, their benefits vary from person to person. Let us explain them.
Altoona Mirror

Understanding risk reduction of statins

Dear Dr. Roach: A cardiologist recently suggested that I should consider taking a statin because of my “borderline” cholesterol level. So, I took a dive into the details of statin therapy. I learned ...
Healio

Meta-analysis questions strength of ties between statin-induced LDL lowering, CV outcomes

Please provide your email address to receive an email when new articles are posted on . “The message has long been that lowering your cholesterol will reduce your risk of heart disease, and that ...
Nasdaq

New REDUCE-IT® Analyses Show VASCEPA® (icosapent ethyl) Associated with 29 Percent Relative Risk Reduction Compared with Placebo in Prespecified Subgroup of Patients with ...

-- Results Presented Today at the American Heart Association (AHA) Scientific Sessions 2023 and Simultaneously Published in the European Heart Journal Open -- DUBLIN, Ireland and BRIDGEWATER, N.J., ...
MedPage Today on MSN

How much efficacy do statin users demand in primary prevention?

Study indicates daunting numbers ...
Medscape

'Striking' Benefit of Lipid Lowering in Primary Prevention

SAN DIEGO – A new analysis of a large-scale trial of a novel lipid-lowering agent has shown a particularly large reduction in cardiovascular events in the primary prevention population enrolled in the ...
Business Wire

Primary endpoint met in the CLEAR Outcomes Trial of bempedoic acid showing statistically significant relative risk reduction in major adverse CV events

Successful topline results from the CLEAR Outcomes Trial demonstrate that bempedoic acid, marketed as NILEMDO ® in Europe, reduces the risk of serious cardiovascular (CV) events in patients with, or ...